ResearcherJohns Hopkins UniversityNo recent work listed
Marcelo Cerullo
Matched on ORCID iD 0000-0002-4551-7682; OpenAlex author ID A5012959376. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2016: 1 paper · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper
Papers 5
- Improved overall survival is still observed in patients receiving delayed adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2020.03.006↗
- Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000002069↗
- Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer. Co-author DOI 10.1007/s00268-017-4021-8↗
- Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer. Co-author DOI 10.1007/s11605-017-3479-x↗
- Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer. Co-author DOI 10.1007/s11605-016-3173-4↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Faiz Gani · 4 shared papers, 2016–2018 · strength 0.33
- Paper Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. DOI 10.1097/sla.0000000000002069↗
- Paper Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cance… DOI 10.1007/s00268-017-4021-8↗
- Paper Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer. DOI 10.1007/s11605-017-3479-x↗
- Timothy Michael Pawlik · 4 shared papers, 2016–2018 · strength 0.33
- Paper Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. DOI 10.1097/sla.0000000000002069↗
- Paper Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cance… DOI 10.1007/s00268-017-4021-8↗
- Paper Hospital Volume and the Costs Associated with Surgery for Pancreatic Cancer. DOI 10.1007/s11605-017-3479-x↗
- Sophia Y. Chen · 3 shared papers, 2016–2018 · strength 0.26
- Paper Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer. DOI 10.1097/sla.0000000000002069↗
- Paper Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cance… DOI 10.1007/s00268-017-4021-8↗
- Paper Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer. DOI 10.1007/s11605-016-3173-4↗
- James L. Abbruzzese · 1 shared paper, 2020 · strength 0.12
- Mohamed A. Adam · 1 shared paper, 2020 · strength 0.12
- Megan C. Turner · 1 shared paper, 2020 · strength 0.12
- Dan German Blazer · 1 shared paper, 2020 · strength 0.12
- Sabran J. Masoud · 1 shared paper, 2020 · strength 0.12
- Sabino Zani · 1 shared paper, 2020 · strength 0.12
- Joseph M. Herman · 1 shared paper, 2018 · strength 0.09
- Daniel A. Laheru · 1 shared paper, 2018 · strength 0.09
- Fabian Mc. Johnston · 1 shared paper, 2017 · strength 0.08
- Mary E. Dillhoff · 1 shared paper, 2017 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.